IRIS Accounts Production v25.1.4.42 06754935 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh067549352023-09-30067549352024-09-30067549352023-10-012024-09-30067549352022-09-30067549352022-10-012023-09-30067549352023-09-3006754935ns15:EnglandWales2023-10-012024-09-3006754935ns14:PoundSterling2023-10-012024-09-3006754935ns10:Director12023-10-012024-09-3006754935ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3006754935ns10:SmallEntities2023-10-012024-09-3006754935ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3006754935ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3006754935ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3006754935ns10:FullAccounts2023-10-012024-09-3006754935ns5:CurrentFinancialInstruments2024-09-3006754935ns5:CurrentFinancialInstruments2023-09-3006754935ns5:Non-currentFinancialInstruments2024-09-3006754935ns5:Non-currentFinancialInstruments2023-09-3006754935ns5:ShareCapital2024-09-3006754935ns5:ShareCapital2023-09-3006754935ns5:CapitalRedemptionReserve2024-09-3006754935ns5:CapitalRedemptionReserve2023-09-3006754935ns5:RetainedEarningsAccumulatedLosses2024-09-3006754935ns5:RetainedEarningsAccumulatedLosses2023-09-3006754935ns10:RegisteredOffice2023-10-012024-09-300675493512023-10-012024-09-3006754935ns5:LandBuildings2023-09-3006754935ns5:LandBuildings2023-10-012024-09-3006754935ns5:LandBuildings2024-09-3006754935ns5:LandBuildings2023-09-3006754935ns5:CostValuation2023-09-3006754935ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3006754935ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3006754935ns5:Secured2024-09-3006754935ns5:Secured2023-09-30
REGISTERED NUMBER: 06754935 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 September 2024

for

Oxicoco Ltd

Oxicoco Ltd (Registered number: 06754935)

Contents of the Financial Statements
for the Year Ended 30 September 2024










Page

Balance Sheet 1

Notes to the Financial Statements 3


Oxicoco Ltd (Registered number: 06754935)

Balance Sheet
30 September 2024

30.9.24 30.9.23
Notes £ £
Fixed assets
Tangible assets 5 133,920 137,640
Investments 6 782 782
134,702 138,422

Current assets
Debtors 7 27,950 39,740
Cash at bank and in hand 7,226 13,505
35,176 53,245
Creditors
Amounts falling due within one year 8 (104,834 ) (99,912 )
Net current liabilities (69,658 ) (46,667 )
Total assets less current liabilities 65,044 91,755

Creditors
Amounts falling due after more than one
year

9

(47,442

)

(62,975

)
Net assets 17,602 28,780

Capital and reserves
Called up share capital 1,745 1,611
Capital redemption reserve 480 480
Retained earnings 15,377 26,689
17,602 28,780

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Oxicoco Ltd (Registered number: 06754935)

Balance Sheet - continued
30 September 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 June 2025 and were signed on its behalf by:





Mrs A M Harvey - Director


Oxicoco Ltd (Registered number: 06754935)

Notes to the Financial Statements
for the Year Ended 30 September 2024


1. Statutory information

Oxicoco Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 06754935

Registered office: 78 Chapel Street
King's Lynn
Norfolk
PE30 1EF

The presentation currency of the financial statements is the Pound Sterling (£).


2. Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have taken advantage of early adopting the Amendments to FRS 102 - Triennial Review 2017: Incremental improvements and clarifications. The entity is electing to carry investment properties rented to another group entity as property, plant and equipment. This transition has been applied using the full retrospective application (all previous fair value uplifts have been unwound and restated to depreciated historical cost).

3. Accounting policies

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Preparation of consolidated financial statements
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.

Critical accounting judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Oxicoco Ltd (Registered number: 06754935)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024


3. Accounting policies - continued

Tangible fixed assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Freehold property - 2% straight line

Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.

For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Oxicoco Ltd (Registered number: 06754935)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024


3. Accounting policies - continued

Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised. Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Oxicoco Ltd (Registered number: 06754935)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024


3. Accounting policies - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Government grants
Government grants are recognised at the fair value of the asset received or receivable. Grants are not recognised until there is reasonable assurance that the company will comply with the conditions attaching to them and the grants will be received.

Government grants are recognised using the accrual model.

Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable.

Grants relating to assets are recognised in income on a systematic basis over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income and not deducted from the carrying amount of the asset.

4. Employees and directors

The average number of employees during the year was 4 (2023 - 4 ) .

Oxicoco Ltd (Registered number: 06754935)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024


5. Tangible fixed assets
Freehold
property
£
Cost
At 1 October 2023
and 30 September 2024 186,000
Depreciation
At 1 October 2023 48,360
Charge for year 3,720
At 30 September 2024 52,080
Net book value
At 30 September 2024 133,920
At 30 September 2023 137,640

6. Fixed asset investments
Shares in
group
undertakings
£
Cost
At 1 October 2023
and 30 September 2024 782
Net book value
At 30 September 2024 782
At 30 September 2023 782

7. Debtors: amounts falling due within one year
30.9.24 30.9.23
£ £
Amounts owed by group undertakings 24,812 38,473
Other debtors 3,138 1,267
27,950 39,740

Oxicoco Ltd (Registered number: 06754935)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024


8. Creditors: amounts falling due within one year
30.9.24 30.9.23
£ £
Bank loans and overdrafts 16,535 16,037
Amounts owed to group undertakings 13,130 -
Taxation and social security 25,362 31,313
Other creditors 49,807 52,562
104,834 99,912

9. Creditors: amounts falling due after more than one year
30.9.24 30.9.23
£ £
Bank loans 47,442 62,975

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 4,485 11,213

10. Secured debts

The following secured debts are included within creditors:

30.9.24 30.9.23
£ £
Bank loans 63,977 79,012

Bank loans are secured by a fixed and floating charge over the assets of the company.

11. Related party disclosures

During the year dividends totalling £116,778 were paid to the shareholders of the company (2023: £111,212).

The company has taken advantage of the exemption provided in FRS 102 Section 1A from disclosing transactions with members of the group that are wholly owned.